Cytokinetics, Incorporated Revenue 1999–2025
Cytokinetics, Incorporated reported $88.04M of revenue for fiscal 2025. That was 376.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +57.7%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $88.04M | +376.6% |
| FY 2024 | $18.47M | +145.3% |
| FY 2023 | $7.53M | -92.0% |
| FY 2022 | $94.59M | +34.3% |
| FY 2021 | $70.43M | +26.2% |
| FY 2020 | $55.83M | +107.8% |
| FY 2019 | $26.87M | -14.7% |
| FY 2018 | $31.50M | +135.6% |
| FY 2017 | $13.37M | -87.4% |
| FY 2016 | $106.41M | +271.3% |
| FY 2015 | $28.66M | -38.9% |
| FY 2014 | $46.94M | +53.2% |
| FY 2013 | $30.65M | +305.5% |
| FY 2012 | $7.56M | +89.0% |
| FY 2011 | $4.00M | +55.2% |
| FY 2010 | $2.58M | -96.8% |
| FY 2009 | $81.54M | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
| FY 2006 | $0 | — |
| FY 2005 | $0 | — |
| FY 2004 | $0 | — |
| FY 2003 | $0 | — |
| FY 2002 | $0 | — |
| FY 2001 | $0 | — |
| FY 2000 | $0 | — |
| FY 1999 | $0 | — |
Source: Cytokinetics, Incorporated SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CYTK 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Cytokinetics, Incorporated reported $88.04M of revenue for fiscal 2025. That was 376.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +57.7%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Cytokinetics, Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytokinetics, Incorporated — frequently asked questions
What is Cytokinetics, Incorporated's revenue?
Cytokinetics, Incorporated (CYTK) reported revenue of $88.04M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Cytokinetics, Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.